Speakers

Paul Alloway

Vice President & Head of Legal at Foghorn Therapeutics (Cambridge, MA)

Greg Bell

Group Vice President and Life Sciences Practice Leader at Charles River Associates (Boston, MA)

Matt Blischak

Vice President, Intellectual Property Counsel at Roivant Sciences, Inc. (New York, NY)

Nicholas Boivin

Chief Intellectual Property Counsel at Forma Therapeutics (Watertown, MA)

Ralph W. Carmichael

Chairman & Chief Executive Officer at BŌNWRx Ltd. (Lansing, MI)

Catherine Eckenswiller

Legal Counsel – Intellectual Property & Agreements at VBI Vaccines Inc. (Ottawa, CA)

Jeffrey J. Ellison, Ph.D.

Partner at Clark + Elbing LLP (Boston, MA)

Geoffrey Taylor Gibbs

Deputy General Counsel, Business, Finance and Innovation at University of California, Office of the President (Oakland, CA)

Kimya Harris, Ph.D.

Vice President, Head of Intellectual Property and Legal Affairs at KSQ Therapeutics (Cambridge, MA)

Drew Holmes, Ph.D.

Senior Patent Attorney at Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Thomas L. Irving

Partner at Finnegan Henderson Farabow Garrett & Dunner LLP (Washington, DC)

Brenda Jarrell, Ph.D.

Co-Chair of Intellectual Property and Life Sciences at Choate, Hall & Stewart LLP (Boston, MA)

Philip Johnson

Former Senior VP for IP Policy & Strategy at Johnson & Johnson (New Brunswick, NJ)

Mark D. Kafka

Associate Director, Assistant General Counsel at Genentech, Inc. (South San Francisco, CA)

Lacy Kolo, Ph.D.

Director, Tech and IP Advisory at Houlihan Lokey (McLean, VA)

John Krayacich

Vice-President & Head, Business Development & Licensing at Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Examining the Due Diligence Inner Sanctum

November 29, 2018 11:15 am

Forrester J. Liddle Ph.D., J.D.

Director of Intellectual Property at Jounce Therapeutics (Cambridge, MA)

Jane M. Love, Ph.D.

Partner at Gibson, Dunn & Crutcher LLP (New York, NY)

Donna Meuth

Associate General Counsel – Intellectual Property at Eisai Inc. (Andover, MA)

The Honorable Paul R. Michel (Ret.)

Former Chief Judge at United States Court of Appeals for the Federal Circuit (Alexandria, VA)

Ahmed Mousa, J.D.

Vice President, Licensing, IP & Legal Affairs at Pieris Pharmaceuticals Inc. (Boston, MA)

Melanie R. Rupert

Partner, Life Sciences IP Litigation Global Co-Chair, Talent Development at Paul Hastings (New York, NY)

Jennifer Zarutskie Sieczkiewicz

Vice President, Chief Intellectual Property Counsel at Wave Life Sciences (Cambridge, MA)

Len Smith

Principal Counsel and Co-Founder at Transformative Legal (Scottsdale, AZ)

Gary J. Speier

Shareholder at Carlson Caspers Vandenburgh Lindquist & Schuman, PA (Minneapolis, MN)

Frederick K. Young, Ph.D.

Due Diligence Head CM and NS at Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Examining the Due Diligence Inner Sanctum

November 29, 2018 11:15 am